Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan

被引:37
|
作者
Khan, Imran [1 ]
Ahmad, Nafees [1 ]
Khan, Shereen [2 ]
Muhammad, Shafi [3 ]
Khan, Shabir Ahmad [4 ]
Ahmad, Izaz [5 ]
Khan, Asad [1 ]
Gulalai [1 ]
Atif, Muhammad [6 ]
机构
[1] Univ Baluchistan Quetta, Fac Pharm & Hlth Sci, Dept Pharm Practice, Quetta, Pakistan
[2] Bolan Med Coll Quetta, Quetta, Pakistan
[3] Univ Baluchistan Quetta, Fac Pharm & Hlth Sci, Dept Pharmacognosy, Quetta, Pakistan
[4] Univ Baluchistan Quetta, Ctr Excellence Vaccinol & Biotechnol, Quetta, Pakistan
[5] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan
[6] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Pakistan
关键词
Baluchistan; Body weight; Death; MDR-TB; Ofloxacin; RISK-FACTORS; PROGRAMMATIC MANAGEMENT; LATENT TUBERCULOSIS; RATES; PREVALENCE; PREDICTORS; DEATH;
D O I
10.1016/j.jiph.2019.04.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Evaluating treatment outcomes of a cohort of patients is an effective way for analyzing the effectiveness of a program. Information regarding drug resistance pattern, detailed management, treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant (MDR-TB) patients is missing from Baluchistan province of Pakistan. Methods This study was carried out at Programmatic Management of Drug Resistant TB unit at Fatimah Jinnah General and Chest Hospital Quetta. All eligible 186 MDR-TB patients enrolled at the study site from January 1, 2012 to April 30, 2016 were retrospectively followed until the treatment outcomes were reported. Data was abstracted through a standardized data collection form and analysed by SPSS 20. Multivariate binary logistic regression (MVBLR) analysis was used to evaluate factors associated with i) death and treatment failure and ii) lost to follow up. A p-value of <0.05 was considered statistically significant. Results The study participants were resistant to a median of four drugs (range 28) with majority being resistant to any second-line anti-TB drug (SLD) (55.5%). Among SLD, resistance was highest for ofloxacin (52.2%). The study site had an overall treatment success rate of 71.6%. A total of 129 (69.4%) patients were cured, four (2.2%) completed treatment, 37 died (19.9%), 14 (7.5%) were lost to follow up and two (1.1%) were declared treatment failures. In MVBLR analysis, patients age of >40 years (OR?=?4.249, p-value?=?0.001) had statistically significant positive and baseline body weight of >40?kg (OR?=?0.256, p-value?=?0.002) had statistically significant negative association with death and treatment failure. No factor had statistical significant association with lost to follow up. Conclusion Overall treatment success rate was promising but did not achieve the target success rate (>75%) set by World Health Organization. It can be further improved by paying special attention and providing enhanced management to the patients with risk factors for unsuccessful outcomes. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.orgg/licensesiby-nc-nd/4.0/).
引用
收藏
页码:809 / 815
页数:7
相关论文
共 50 条
  • [21] Factors Associated with Treatment Outcomes in Drug-Resistant Tuberculosis
    Putra, Oki Nugraha
    Hidayatullah, Affan Yuniar Nur
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2022, 11 (02) : 226 - 227
  • [22] More on Treatment Outcomes in Multidrug-Resistant Tuberculosis
    Brust, James C. M.
    Shah, N. Sarita
    Gandhi, Neel R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26): : 2610 - 2610
  • [23] Changes in treatment outcomes of multidrug-resistant tuberculosis
    Kwak, N.
    Kim, H-R.
    Yoo, C-G.
    Kim, Y. W.
    Han, S. K.
    Yim, J-J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (06) : 708 - 708
  • [24] Changes in treatment outcomes of multidrug-resistant tuberculosis
    Kwak, N.
    Kim, H-R
    Yoo, C-G
    Kim, Y. W.
    Han, S. K.
    Yim, J-J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (05) : 525 - 530
  • [25] Treatment outcomes of multidrug-resistant tuberculosis in Switzerland
    Helbling, Peter
    Altpeter, Ekkehardt
    Egger, Jean-Marie
    Zellweger, Jean-Pierre
    SWISS MEDICAL WEEKLY, 2014, 144
  • [26] Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine
    Pedersen, Ole Skouvig
    Butova, Tetiana
    Kapustnyk, Valeriy
    Miasoiedov, Valerii
    Kuzhko, Mykhailo
    Hryshchuk, Leonid
    Kornaha, Svitlana
    Borovok, Natalia
    Raznatovska, Olena
    Fedorec, Andrii
    Bogomolov, Artemii
    Tkhorovskiy, Mykhaylo
    Akymenko, Oleksandra
    Klymenko, Iurii
    Kulykova, Olena
    Karpenko, Zhanna
    Shapoval, Tetiana
    Chursina, Nataliia
    Kondratyuk, Natalia
    Parkhomenko, Olha
    Sazonenko, Inna
    Ostrovskyy, Mykola
    Makoida, Iryna
    Markovtsiy, Lyubov
    Skryp, Vasyl
    Lubenko, Victoriya
    Hrankina, Nataliia
    Bondarenko, Leonid
    Hlynenko, Valentyna
    Dahl, Victor Naestholt
    Butov, Dmytro
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (03) : 360 - 367
  • [27] Examine the Successful and Unsuccessful Treatment Outcomes of Patients with Tuberculosis
    Taj, Muhammad Haroon
    Tauseef, Muhammad Atif
    Ayaz, Muhammad
    Umair-Ul-Islam
    Mumtaz, Arif
    Ahmad, Rashid
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2020, 14 (02): : 1563 - 1565
  • [28] IMPROVED OUTCOMES FOR PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
    TURETT, GS
    TELZAK, EE
    TORIAN, LV
    BLUM, S
    ALLAND, D
    WEISFUSE, I
    FAZAL, BA
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) : 1238 - 1244
  • [29] Factors Associated with Unsuccessful Outcomes of Tuberculosis Treatment in 125 Municipalities in Colombia 2014 to 2016
    Paniagua-Saldarriaga, Lizeth Andrea
    Pelissari, Daniele Maria
    Rueda, Zulma Vanessa
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 1326 - 1334
  • [30] Long-term treatment outcomes in patients with multidrug-resistant tuberculosis
    Maier, Christina
    Chesov, Dumitru
    Schaub, Dagmar
    Kalsdorf, Barbara
    Andres, Sonke
    Friesen, Inna
    Reimann, Maja
    Lange, Christoph
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (06) : 751 - 757